Tag: drug-coated balloons market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Trajectory for the Drug-Coated Balloons Market by 2033?

The market size for drug-coated balloons has experienced rapid expansion in the past few years. It is projected to increase from $0.95 billion in 2023 to $1.1 billion in 2024, representing a compound annual growth rate (CAGR) of 16.3%. The past growth of this market is primarily due to the rise in cardiovascular disease occurrences, the preference for less invasive medical procedures, the prevalence of peripheral artery disease (pad), reduced rates of restenosis, and advancements in the field of interventional cardiology.

The market for drug-coated balloons is projected to experience a substantial increase in the coming years, expected to reach $1.93 billion by the year 2028 with a Compound Annual Growth Rate (CAGR) of 15.0%. Contributing factors to this growth during the forecast period include a rise in the aging population, widening of indications and applications, emphasis on outpatient and ambulatory care, integration with advancements in drug delivery systems, and worldwide health initiatives. The forecast period also sees key trends such as obtaining regulatory approval for new types of formulations, reducing side effects, the advent of bioresorbable coatings, market development in emerging economies, and adopting patient-focused methods.

Claim Your Free Sample of the Global Drug-Coated Balloons Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Factors Are Leading to Growth in the drug-coated balloons Market?

The growing incidence of coronary artery disease (CAD) promises to stimulate the progression of the market for drug-coated balloons. Characterized by the constriction or blockage of coronary arteries that supply blood to the heart muscle, CAD often results in heart attacks. Drug-coated balloons, which dispense medication into the artery during the procedure, are employed in CAD treatment to deter restenosis, i.e., the recurrence of artery constriction post angioplasty. A case in point is May 2023 when a Centers for Disease Control and Prevention report disclosed that fatalities due to coronary heart disease in the United States rose to 375,476 in 2021, and approximately 1 in 20 adults aged 20 and over were found to have coronary heart disease. The rising CAD incidence, therefore, is anticipated to prime the growth of the drug-coated balloon market.

Which Segments Play a Key Role in Understanding the Drug-Coated Balloons Market?

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

What Trends Are Emerging as Game-Changers in the Drug-Coated Balloons Market?

The surge in product invention is a crucial trend amassing interest in the drug-coated balloons market. Key players in this area are zeroing in on the establishment of advanced and inventive solutions to consolidate their market position. In July 2021, Medtronic plc, a United States-based medical device developer, introduced the Prevail drug-coated balloon (DCB) Catheter. This sophisticated instrument is utilized during percutaneous coronary intervention (PCI) procedures to help patients suffering from coronary artery disease (CAD), who have occluded or narrowed coronary arteries. It focuses therapy delivery to the site of the blockage using paclitaxel, a drug renowned for its quick absorption. This ensures efficient treatment of numerous types of lesions, such as in-stent restenosis (ISR), small vascular disease, and new lesions.

Order Now for Fast Delivery of Your Drug-Coated Balloons Market Report!

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Regions Are Setting the Pace for Drug-Coated Balloons Market Growth?

North America was the largest region in the global drug-coated balloons market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Drug-Coated Balloons Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the drug-coated balloons market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Drug-Coated Balloons Market Include

1. Drug-Coated Balloons Market Executive Summary

2. Drug-Coated Balloons Market Segments

3. Drug-Coated Balloons Market Size And Template Market Growth Rate

4. Key Drug-Coated Balloons Market Trends

5. Major Drug-Coated Balloons Market Drivers

……

25. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

26. Top Drug-Coated Balloons Companies

27. Drug-Coated Balloons Market Opportunities And Strategies

28. Drug-Coated Balloons Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Sunglasses Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sunglasses-global-market-report

Hematology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Introduction: The Market Landscape

• Rapid Growth: From $0.95 billion in 2023 to $1.1 billion in 2024 at a CAGR of 16.3%
• Historic Period Factors: Increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (PAD), reducing restenosis rates, advancements in interventional cardiology.

Projections and Trends for the Drug-Coated Balloons Market

• Forecasted Growth: Expected to reach $1.93 billion in 2028 at a CAGR of 15.0%
• Forecast Period Factors: Increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives.
• Major Trends: Regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

Rising Prevalence Of Coronary Artery Disease Drives Growth In The Drug-Coated Balloons Market

• Coronary Artery Disease (CAD) Overview: Defined by the narrowing or obstruction of the coronary arteries, leading to heart attacks.
• Role of Drug-Coated Balloons: Used to prevent restenosis post-angioplasty.
• Prevalence Statistics: Significant increase in CAD cases, notably in the United States.
• Market Players: Acotec Scientific AG, AR Baltic Medical AB, B. Braun Melsungen AG, and others.

View More On The Drug-Coated Balloons Market Report 2024 – https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Product Innovations For Enhanced Treatment In Coronary Artery Disease

• Key Trend: Focus on product innovations to enhance treatment efficacy.
• Example: Medtronic PLC’s Prevail drug-coated balloon (DCB) Catheter for percutaneous coronary intervention (PCI) operations.
• Acquisitions: Cordis’s acquisition of Med Alliance SA to expand its cardiovascular portfolio.

Segmentation and Market Dynamics

• Market Segments:
  1. By Product: Drug-Coated Balloons for Peripheral Artery Disease, Coronary Artery Disease, and Other Indications.
  2. By Drug Type: Paclitaxel, Sirolimus.
  3. By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers.
• Regional Insights: North America leading in 2023, with expected continued growth.

Conclusion: Looking Ahead

• The drug-coated balloons market is poised for significant expansion, driven by technological innovations, increasing prevalence of cardiovascular diseases, and strategic acquisitions.
• Market players are focusing on meeting the evolving demands of healthcare with patient-centric solutions and expanding their global footprint.
• As the market continues to evolve, regulatory compliance, patient safety, and technological advancements will remain key focal points for stakeholders in the drug-coated balloons industry.

The drug-coated balloons market stands at the intersection of innovation and healthcare, poised to address the growing burden of cardiovascular diseases globally. With a robust growth trajectory and a landscape ripe for innovation, the market presents significant opportunities for companies to make a lasting impact on patient care and outcomes.

Request A Sample Of The Global Drug-Coated Balloons Market Report 2024:

https://www.thebusinessresearchcompany.com/sample_request?id=10829&type=smp